logo-loader
NASDAQ:BHST

BioHarvest Sciences Inc

Receive alerts
Market:
NASDAQ
Price
1.21 USD
Day Change
1.68%
Market Cap:
$27.88 m
52 weeks high
7.12
52 weeks low
0.92

In brief

BioHarvest is a leader in Botanical Synthesis, leveraging its patented technology platform to grow plant-based compounds, without the need to grow the underlying plant.

The company is leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business verticals; as a contract development and production organization (CDMO) on behalf of customers seeking novel plant-based compounds, and as a creator of proprietary nutraceutical health and wellness products, which includes dietary supplements.

Snapshot

  • BioHarvest Sciences posts US$7.9M Q3 revenue as fragrance supply deal sets up 2027 growth
  • BioHarvest Sciences Partners with Tate & Lyle to Develop Sustainable Plant-Based Sweeteners